• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新冠病毒疾病的发病机制——潘多拉魔盒中疫情的混乱局面。

Pathogenesis of covid - 19 - Pandemonium of the pandemic in Pandora's box.

作者信息

Goyal Aditi, Shukla Samarth, Acharya Sourya, Vagha Sunita, Goyal Venkat, Goyal Madhvi

机构信息

Department of Pathology, Jawaharlal Nehru Medical College, Datta Meghe Institute of Medical Sciences, Wardha, Maharashtra, India.

Department of Medicine, Jawaharlal Nehru Medical College, Datta Meghe Institute of Medical Sciences, Wardha, Maharashtra, India.

出版信息

J Family Med Prim Care. 2021 Dec;10(12):4376-4382. doi: 10.4103/jfmpc.jfmpc_34_21. Epub 2021 Dec 27.

DOI:10.4103/jfmpc.jfmpc_34_21
PMID:35280638
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8884312/
Abstract

The novel disease of 2019 by name coronavirus (Covid - 19 or SARS - CoV - 2), was first detected in December of 2019 in the Seafood Market of Huanan in Wuhan region of China. In less than a month it was proclaimed as a pandemic by The World Health Organization (WHO). Now, even after a year, it still remains to be a concern as a jeopardy to the global public health. The inception of Covid-19 has been identified as the third encounter of a highly morbific coronavirus after Severe Acute Respiratory Syndrome (SARS - CoV) and Middle East Respiratory Syndrome (MERS_CoV) causing coronaviruses, in merely two decades. In this review, we illustrate the general features of coronavirus and highlight the pathogenesis of the disease, bringing forth the different theories of disease progression, which may help clinicians and other health professionals to achieve a direction for further research, therapeutic protocols and development of the vaccine for combating SARS - CoV - 2 infection.

摘要

这种名为冠状病毒(新冠病毒 - 19 或严重急性呼吸综合征冠状病毒 2)的新型疾病于 2019 年 12 月首次在中国武汉地区的华南海鲜市场被发现。不到一个月,它就被世界卫生组织(WHO)宣布为大流行病。如今,即便在一年之后,它作为对全球公共卫生的一种威胁,仍然令人担忧。新冠病毒 - 19 的出现被认定为是在仅仅二十年时间里,继严重急性呼吸综合征(SARS - CoV)和中东呼吸综合征(MERS - CoV)这两种致病性很强的冠状病毒之后,人类第三次遭遇高致病性冠状病毒。在这篇综述中,我们阐述了冠状病毒的一般特征,并突出了该疾病的发病机制,提出了不同的疾病进展理论,这可能有助于临床医生和其他卫生专业人员为进一步研究、治疗方案以及对抗严重急性呼吸综合征冠状病毒 2 感染的疫苗研发找到方向。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d093/8884312/31a523859464/JFMPC-10-4376-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d093/8884312/22cb256341cb/JFMPC-10-4376-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d093/8884312/e01c8a136cde/JFMPC-10-4376-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d093/8884312/31a523859464/JFMPC-10-4376-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d093/8884312/22cb256341cb/JFMPC-10-4376-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d093/8884312/e01c8a136cde/JFMPC-10-4376-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d093/8884312/31a523859464/JFMPC-10-4376-g003.jpg

相似文献

1
Pathogenesis of covid - 19 - Pandemonium of the pandemic in Pandora's box.新冠病毒疾病的发病机制——潘多拉魔盒中疫情的混乱局面。
J Family Med Prim Care. 2021 Dec;10(12):4376-4382. doi: 10.4103/jfmpc.jfmpc_34_21. Epub 2021 Dec 27.
2
Human and novel coronavirus infections in children: a review.儿童人感染和新型冠状病毒感染:综述。
Paediatr Int Child Health. 2021 Feb;41(1):36-55. doi: 10.1080/20469047.2020.1781356. Epub 2020 Jun 25.
3
A comparative review of pathogenesis and host innate immunity evasion strategies among the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), severe acute respiratory syndrome coronavirus (SARS-CoV) and the Middle East respiratory syndrome coronavirus (MERS-CoV).严重急性呼吸综合征冠状病毒 2 (SARS-CoV-2)、严重急性呼吸综合征冠状病毒 (SARS-CoV) 和中东呼吸综合征冠状病毒 (MERS-CoV) 的发病机制和宿主固有免疫逃避策略的比较综述。
Arch Microbiol. 2021 Jul;203(5):1943-1951. doi: 10.1007/s00203-021-02265-y. Epub 2021 Mar 7.
4
COVID-19 in the Shadows of MERS-CoV in the Kingdom of Saudi Arabia.沙特阿拉伯 COVID-19 在 MERS-CoV 的阴影下。
J Epidemiol Glob Health. 2020 Mar;10(1):1-3. doi: 10.2991/jegh.k.200218.003.
5
The British variant of the new coronavirus-19 (Sars-Cov-2) should not create a vaccine problem.新冠病毒-19(Sars-Cov-2)的英国变体不应造成疫苗问题。
J Biol Regul Homeost Agents. 2021 Jan-Feb;35(1):1-4. doi: 10.23812/21-3-E.
6
Coronavirus disease 2019: A new severe acute respiratory syndrome from Wuhan in China.2019冠状病毒病:一种源自中国武汉的新型严重急性呼吸综合征。
Acta Virol. 2020;64(2):245-250. doi: 10.4149/av_2020_201.
7
Coronaviruses - a new old menace.冠状病毒——新的旧威胁。
Postepy Biochem. 2021 Jan 5;66(4):303-308. doi: 10.18388/pb.2020_357. Print 2020 Dec 31.
8
Novel coronavirus 2019-nCoV: prevalence, biological and clinical characteristics comparison with SARS-CoV and MERS-CoV.新型冠状病毒 2019-nCoV:流行情况、与 SARS-CoV 和 MERS-CoV 的生物学和临床特征比较。
Eur Rev Med Pharmacol Sci. 2020 Feb;24(4):2012-2019. doi: 10.26355/eurrev_202002_20379.
9
Pathological diagnosis of Coronavirus-related nephropathy: insight from postmortem studies.冠状病毒相关性肾病的病理诊断:来自尸检研究的见解。
Crit Rev Clin Lab Sci. 2021 Dec;58(8):563-575. doi: 10.1080/10408363.2021.1944047. Epub 2021 Jul 8.
10
SARS-CoV-2 and Coronavirus Disease 2019: What We Know So Far.严重急性呼吸综合征冠状病毒2型与2019冠状病毒病:我们目前所了解的情况。
Pathogens. 2020 Mar 20;9(3):231. doi: 10.3390/pathogens9030231.

引用本文的文献

1
Insertion/deletion (I/D) polymorphisms of angiotensin-converting enzyme gene and their implications for susceptibility and severity of COVID-19: A systematic review and meta-analysis.血管紧张素转换酶基因插入/缺失(I/D)多态性及其与2019冠状病毒病易感性和严重程度的关系:一项系统评价和荟萃分析。
Narra J. 2024 Dec;4(3):e727. doi: 10.52225/narra.v4i3.727. Epub 2024 Dec 21.

本文引用的文献

1
Imaging Profile of the COVID-19 Infection: Radiologic Findings and Literature Review.新型冠状病毒肺炎感染的影像学表现:放射学发现与文献综述
Radiol Cardiothorac Imaging. 2020 Feb 13;2(1):e200034. doi: 10.1148/ryct.2020200034. eCollection 2020 Feb.
2
The cytokine storm in COVID-19: An overview of the involvement of the chemokine/chemokine-receptor system.COVID-19 中的细胞因子风暴:趋化因子/趋化因子受体系统的参与概述。
Cytokine Growth Factor Rev. 2020 Jun;53:25-32. doi: 10.1016/j.cytogfr.2020.05.003. Epub 2020 May 11.
3
Neutrophil-to-lymphocyte ratio predicts critical illness patients with 2019 coronavirus disease in the early stage.
中性粒细胞与淋巴细胞比值可预测 2019 冠状病毒病重症患者的早期病情。
J Transl Med. 2020 May 20;18(1):206. doi: 10.1186/s12967-020-02374-0.
4
The pathogenesis and treatment of the `Cytokine Storm' in COVID-19.新型冠状病毒病中“细胞因子风暴”的发病机制与治疗。
J Infect. 2020 Jun;80(6):607-613. doi: 10.1016/j.jinf.2020.03.037. Epub 2020 Apr 10.
5
Kidney disease is associated with in-hospital death of patients with COVID-19.肾病与 COVID-19 患者住院期间的死亡相关。
Kidney Int. 2020 May;97(5):829-838. doi: 10.1016/j.kint.2020.03.005. Epub 2020 Mar 20.
6
Antibody Responses to SARS-CoV-2 in Patients With Novel Coronavirus Disease 2019.新型冠状病毒病 2019 患者的 SARS-CoV-2 抗体反应。
Clin Infect Dis. 2020 Nov 19;71(16):2027-2034. doi: 10.1093/cid/ciaa344.
7
Cardiac Involvement in a Patient With Coronavirus Disease 2019 (COVID-19).新冠肺炎(COVID-19)患者的心脏受累。
JAMA Cardiol. 2020 Jul 1;5(7):819-824. doi: 10.1001/jamacardio.2020.1096.
8
Autopsy in suspected COVID-19 cases.疑似 COVID-19 病例的尸检。
J Clin Pathol. 2020 May;73(5):239-242. doi: 10.1136/jclinpath-2020-206522. Epub 2020 Mar 20.
9
Convalescent plasma as a potential therapy for COVID-19.康复期血浆作为治疗新冠肺炎的一种潜在疗法。
Lancet Infect Dis. 2020 Apr;20(4):398-400. doi: 10.1016/S1473-3099(20)30141-9. Epub 2020 Feb 27.
10
Pathological findings of COVID-19 associated with acute respiratory distress syndrome.与急性呼吸窘迫综合征相关的新型冠状病毒肺炎的病理表现
Lancet Respir Med. 2020 Apr;8(4):420-422. doi: 10.1016/S2213-2600(20)30076-X. Epub 2020 Feb 18.